National Health Investors, Inc. (NHI)
National Health Investors: The Silver Tsunami Makes This REIT Undervalued
National Health Investors, Inc. remains a Buy, supported by strong financials, an attractive valuation, and a sustainable ~5% dividend yield. NHI's $560M asset sale and $107M SHOP investment accelerate its transition to the Senior Housing Operating Portfolio model, enhancing growth potential. Pro forma net debt/EBITDA expected at 2.3x following NHI's major sale and a ~74.5% FAD payout ratio based on guidance highlight NHI's balance sheet strength and dividend flexibility.
National Health Investors: An Investment-Grade Healthcare REIT With Portfolio Growth And More
National Health Investors is rated a buy, driven by robust macro demand for senior care, portfolio expansion, and a compelling 5% dividend yield. NHI demonstrates strong top-line growth, geographic diversity, and resilient 5-year revenue trends, with recent acquisitions further solidifying its market presence. Despite modest FFO growth expectations and technical bearishness, NHI benefits from an investment-grade Fitch rating, prudent leverage, and strong ROE among peers.
Implied Volatility Surging for National Health Investors Stock Options
Investors need to pay close attention to NHI stock based on the movements in the options market lately.
National Health Investors, Inc. (NHI) Q1 2026 Earnings Call Transcript
National Health Investors, Inc. (NHI) Q1 2026 Earnings Call Transcript
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.24 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to FFO of $1.15 per share a year ago.
DOC or NHI: Which Is the Better Value Stock Right Now?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Healthpeak (DOC) and National Health Investors (NHI). But which of these two stocks is more attractive to value investors?
National Health Investors: Get Paid As Senior Housing Growth Accelerates
National Health Investors is a healthcare REIT focused on senior housing and skilled nursing, offering both income and growth potential. NHI's FFO per share grew 10.6% in 2025, driven by SHOP platform expansion and stable triple-net lease performance. The current 4.5% dividend yield is well-covered, with resumed growth and a conservative 74% payout ratio, supported by a strong BBB- balance sheet.
National Health Investors, Inc. (NHI) Q4 2025 Earnings Call Transcript
National Health Investors, Inc. (NHI) Q4 2025 Earnings Call Transcript
National Health Investors (NHI) Misses Q4 FFO Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.22 per share, missing the Zacks Consensus Estimate of $1.24 per share. This compares to FFO of $1.13 per share a year ago.
National Health Investors (NHI) Is Up 2.37% in One Week: What You Should Know
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
National Health Investors: A Healthcare REIT Ready For The Senior Housing Supercycle
National Health Investors is rated a Buy thanks to strong financials, manageable debt, and a compelling 4.7% dividend yield. NHI's transition to a SHOP-oriented model is driving normalized FAD growth, with Q3'25 FAD up 26% year-over-year and guidance raised for 2025. A low leverage profile, very attractive debt maturity schedule, and significant liquidity position NHI favorably in the senior housing REIT space.
National Health Investors (NHI) Moves to Buy: Rationale Behind the Upgrade
National Health Investors (NHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
